Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Facelifts can lead to high patient satisfaction and a quick recovery when done correctly.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

A quick and simple method was created to identify minoxidil in hair-growth products using micellar electrokinetic capillary chromatography.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Licorice has many traditional health benefits, but more research is needed to fully support these claims.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Nutricosmetics with active ingredients can help with hair loss and improve hair growth.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.